Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin S Weber

Showing results (21-30 of 134) with videos related to

Pageof 14
Sort By:
Biomedicines|March 28, 2024
Differential Role of Factor XIII in Acute Myocardial Infarction and Ischemic StrokeJan Traub, Martin S Weber, Anna Frey
Trends in Neurosciences|December 15, 2023
Toward identifying key mechanisms of progression in multiple sclerosisLeila Husseini, Anastasia Geladaris, Martin S Weber
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|October 9, 2007
Mechanism of action of glatiramer acetate in treatment of multiple sclerosisMartin S Weber, Reinhard Hohlfeld, Scott S Zamvil
International Journal of Molecular Sciences|July 26, 2020
Differential Effects of MS Therapeutics on B Cells-Implications for Their Use and Failure in AQP4-Positive NMOSD PatientsJan Traub, Silke Häusser-Kinzel, Martin S Weber
Nature Medicine|April 7, 2007
T effectors outfox T regulators in autoimmunityThomas Prod'homme, Martin S Weber, Scott S Zamvil
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|October 9, 2007
Statins--treatment option for central nervous system autoimmune disease?Martin S Weber, Lawrence Steinman, Scott S Zamvil
JAMA Neurology|October 13, 2015
Targeting Central Nervous System B Cells in Progression of Multiple Sclerosis: Is Intrathecal Anti-CD20 a Therapeutic Option?Mahboobeh Fereidan-Esfahani, Wolfgang Brück, Martin S Weber
International Journal of Molecular Sciences|September 27, 2017
Deciphering the Role of B Cells in Multiple Sclerosis-Towards Specific Targeting of Pathogenic FunctionKlaus Lehmann-Horn, Silke Kinzel, Martin S Weber
Neurology(R) Neuroimmunology & Neuroinflammation|April 18, 2023
Natalizumab Promotes Activation of Peripheral Monocytes in Patients With Multiple SclerosisEsther S Frisch, Darius Häusler, Martin S Weber
Nature Reviews. Immunology|July 25, 2023
Trogocytosis challenges the cellular specificity of lineage markers and monoclonal antibodiesJasmin Ochs, Silke Häusser-Kinzel, Martin S Weber
Pageof 14

Showing results (21-30 of 134) with videos related to

Sort By:
Pageof 14
Biomedicines|March 28, 2024
Differential Role of Factor XIII in Acute Myocardial Infarction and Ischemic StrokeJan Traub, Martin S Weber, Anna Frey
Trends in Neurosciences|December 15, 2023
Toward identifying key mechanisms of progression in multiple sclerosisLeila Husseini, Anastasia Geladaris, Martin S Weber
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|October 9, 2007
Mechanism of action of glatiramer acetate in treatment of multiple sclerosisMartin S Weber, Reinhard Hohlfeld, Scott S Zamvil
International Journal of Molecular Sciences|July 26, 2020
Differential Effects of MS Therapeutics on B Cells-Implications for Their Use and Failure in AQP4-Positive NMOSD PatientsJan Traub, Silke Häusser-Kinzel, Martin S Weber
Nature Medicine|April 7, 2007
T effectors outfox T regulators in autoimmunityThomas Prod'homme, Martin S Weber, Scott S Zamvil
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|October 9, 2007
Statins--treatment option for central nervous system autoimmune disease?Martin S Weber, Lawrence Steinman, Scott S Zamvil
JAMA Neurology|October 13, 2015
Targeting Central Nervous System B Cells in Progression of Multiple Sclerosis: Is Intrathecal Anti-CD20 a Therapeutic Option?Mahboobeh Fereidan-Esfahani, Wolfgang Brück, Martin S Weber
International Journal of Molecular Sciences|September 27, 2017
Deciphering the Role of B Cells in Multiple Sclerosis-Towards Specific Targeting of Pathogenic FunctionKlaus Lehmann-Horn, Silke Kinzel, Martin S Weber
Neurology(R) Neuroimmunology & Neuroinflammation|April 18, 2023
Natalizumab Promotes Activation of Peripheral Monocytes in Patients With Multiple SclerosisEsther S Frisch, Darius Häusler, Martin S Weber
Nature Reviews. Immunology|July 25, 2023
Trogocytosis challenges the cellular specificity of lineage markers and monoclonal antibodiesJasmin Ochs, Silke Häusser-Kinzel, Martin S Weber
Pageof 14